3D Systems reported a decrease in revenue for the first quarter of 2025, primarily due to lower materials sales despite growth in new hardware systems and related services. The company is implementing cost reduction initiatives and has withdrawn its full-year guidance due to uncertain customer capital spending.
3D Systems' Q4 2024 revenue fell 3% year-over-year to $111 million, largely due to an $8.7 million adjustment tied to its Regenerative Medicine program. The company posted a net loss of $33.7 million and continued efforts to cut costs, while non-GAAP EPS came in at -$0.19.
3D Systems reported a decrease in revenue by 9% year-over-year, primarily due to macro weakness in printer sales, while healthcare solutions revenue increased by 5%. The company experienced a net loss of $178.6 million, including a $143.7 million impairment charge. They are updating guidance for the remainder of FY'24 to include expected full-year revenues within the range of $440 million - $450 million.
3D Systems reported a 15.1% decrease in revenue to $102.9 million, primarily due to lower printer sales. The company experienced a net loss of $16.0 million, which included $5 million in audit-related fees. Despite these challenges, the company anticipates improved performance in the coming quarters.
3D Systems reported a 13.5% decrease in Q4 revenue compared to the previous year, primarily due to significant softness in dental orthodontics and depressed printer sales. The company experienced a net loss of $300.4 million, largely driven by non-cash impairment charges. Despite the revenue decline, the non-GAAP gross profit margin increased due to product mix improvements.
3D Systems reported a 6.4% decrease in revenue compared to the same period last year, primarily due to lower sales in the dental orthodontics market. However, the company saw improvements in gross profit margin and Adjusted EBITDA, driven by operational efficiencies and favorable mix. A restructuring plan is underway to reduce operating costs and drive internal efficiencies.
3D Systems reported a decrease in revenue for Q2 2023, primarily due to lower sales in the dental orthodontics market. However, the company saw growth in non-dental markets and continued to invest in regenerative medicine. They are adjusting their full-year 2023 revenue expectation to $525 million to $545 million and anticipate positive adjusted EBITDA in Q4 2023.
3D Systems reported a decrease in revenue for Q1 2023 by 8.8% to $121.236 million compared to the same period last year, primarily due to lower sales in the dental market. However, non-dental markets saw a 12.3% increase in revenue on a constant currency basis. The company is maintaining its full-year outlook for revenue, non-GAAP gross profit margin, and free cash flow, while raising its Adjusted EBITDA guidance.
3D Systems' fourth-quarter revenue decreased by 12.0% to $132,732 compared to the same period last year. The decline primarily reflects lower sales to certain dental market customers due to macroeconomic factors.
3D Systems' third quarter results showed a decrease in revenue to $132.3 million due to divestitures, but non-GAAP revenue excluding divestitures and on a constant currency basis grew by 2.7%. The company is focused on operational execution and prudent investments.
3D Systems' second quarter results were below expectations due to supply chain disruptions, input cost inflation, and negative foreign exchange impact. The company is lowering its full-year 2022 guidance due to reduced customer spending in selected end markets. However, the company remains confident in the long-term growth drivers for its business and the additive manufacturing industry.
3D Systems reported a revenue decline of 9.0% compared to Q1 2021, primarily due to divestitures. However, adjusted for divestitures, revenue increased by 10%, driven by growth in both Industrial and Healthcare Solutions segments. The company is narrowing its full-year 2022 revenue guidance to a range of $580 million to $625 million.
3D Systems reported a decrease in Q4 2021 revenue to $150.9 million, which declined 12.6% compared to Q4 2020. This decrease was solely driven by divestitures of non-core assets. However, adjusted for divestitures, Q4 2021 revenue increased by 13.1% compared to Q4 2020. The company reported a GAAP loss per share of $0.05 and a non-GAAP income per share of $0.09.
3D Systems reported a 14.6% increase in revenue for Q3 2021 compared to the same period last year, and a 35.9% increase when excluding businesses divested in 2020 and 2021. The company's cash from operations was $20.7 million, bolstering a balance sheet with $503 million of cash. The company also completed divestitures of non-core assets and began the transition to a strategic growth phase.
3D Systems reported strong second-quarter results, demonstrating significant growth in revenue and profitability. Revenue increased 44.1% year-over-year and 11.3% sequentially. The company's focus on additive manufacturing and strategic divestitures have positioned it for continued growth and investment in core businesses.
3D Systems reported a strong first quarter with revenue growth of 7.7% year-over-year, driven by a 38.7% increase in healthcare revenue. The company achieved GAAP earnings of $0.36 per diluted share and non-GAAP earnings of $0.17 per diluted share. Adjusted EBITDA margins reached 13.6%, and the company generated positive operating cash flow of $28.5 million.
3D Systems reported a 2.6% increase in revenue for Q4 2020 compared to Q4 2019, driven by strong growth in the Healthcare sector. The company achieved non-GAAP operating income of $16.1 million due to restructuring and efficiency improvements.
3D Systems reported a revenue of $135.1 million for Q3 2020, a decrease of 13% compared to Q3 2019, but a 20.6% increase compared to Q2 2020. The company's GAAP loss per share was $0.61, which included a $48.3 million pre-tax non-cash goodwill impairment charge. Non-GAAP loss per share was $0.03. The healthcare sector saw a 6.1% increase in revenue, while industrial sales decreased by 23.8%.
3D Systems reported a decrease in revenue for the second quarter of 2020, primarily due to the impact of the COVID-19 pandemic. The company is focusing on healthcare and industrial markets and implementing restructuring to reduce operating costs by $100 million per year.
3D Systems reported a GAAP revenue of $134.7 million for Q1 2020, compared to $152.0 million in the same period last year. The company experienced a GAAP loss of $0.17 per share, an improvement from the $0.22 loss per share in the same period last year. The COVID-19 pandemic negatively impacted the results. They had cash and cash equivalents of $112.8 million at the end of the quarter.
3D Systems reported a decrease in revenue for Q4 2019 compared to the same period last year, with printer revenue experiencing a significant decline. The company reported a GAAP loss of $0.04 per share, consistent with the previous year, but non-GAAP earnings decreased. Despite macroeconomic challenges, there was growth in materials revenue in the second half of the year, and the company focused on cost structure improvements.